Please login to the form below
6
Revenue 2017Johnson & Johnson
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Johnson & Johnson's 2013 sales performance.
Versiti launches test for vaccine-related blood clot issues
Recently, cases of individuals developing blood clots with low platelet counts have been observed connected to Johnson &Johnson’s COVID-19 vaccine.
J&J resumes US rollout of single-dose COVID-19 vaccine
Rollout of Johnsons &Johnson’s (J&J) COVID-19 vaccine is primed to resume in the US after the US Centers for Disease Control and Prevention (CDC) and Food and Drug ... On 20 April, the European Medicines Agency’s (EMA) Pharmacovigilance Risk
WHO to review Moderna’s COVID-19 vaccine for emergency use listing this week
So far, the AstraZeneca (AZ)/Oxford University, Pfizer/BioNTech and Johnson &Johnson COVID-19 vaccines are the only ones that have received an EUL from the WHO.
J&J halts manufacturing of COVID-19 at US plant after FDA warning
Johnson &Johnson (J&J) has halted manufacturing of its COVID-19 vaccine at a plant in the US after the Food and Drug Administration (FDA) identified ‘ certain conditions’ that could lead
EMA finds overall benefit-risk ‘remains positive’ for J&J COVID-19 vaccine
The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that the overall benefit-risk profile of Johnson &Johnson’s (J&J) COVID-19 vaccine is positive.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Senior & Principal Medical Writer
-
Competitive Salary Offered
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
-
Account Management
-
Competitive Salary Offered
-
Senior Medical Writer
-
Competitive Salary
-
Account Manager
-
Competitive Salary
-
Medical Editor
-
Competitive Salary
-
Publications Director
-
Competitive Salary
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
-
Senior Account Executive
-
Competitive Salary
-
Associate Account Director
-
Competitive Salary
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Merck & Co reveals plans for women’s health spinoff Organon
- Positive results for GSK/CureVac’s COVID-19 vaccine
- EMA launches rolling review of GSK/Vir Biotech’s mAb for early COVID-19
- Biogen and Capsigen to collaborate on gene therapies
- CanSinoBIO considers booster jab for COVID-19 vaccine
- Research Partnership’s MedTech Division appoints two Directors
- VMLY&Rx launches new payer agency in the US
- Biogen and Envisagenics to advance RNA splicing research for CNS diseases
- Positive results for GSK/CureVac’s COVID-19 vaccine
- New trial data for Keytruda in triple-negative breast cancer
- NICE recommends Keytruda for colorectal cancer patients with rare mutations
- US states claim Purdue Pharma owes $2.2 trillion over opioid crisis
- Working in true partnership in a time of change
- Alderley Park 'will remain flagship bioscience location'
- CanSinoBIO considers booster jab for COVID-19 vaccine
- Moderna agrees to supply Gavi with 500 million doses for COVAX
- Pfizer’s COVID-19 vaccine yields $3.5bn in first quarter sales
PMHub
Dovetail
We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...
Latest intelligence
- How innovating study sites can improve patient recruitment efficiency
- There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
- Avoiding A Series of Unfortunate Events: launch lessons from lockdown
- Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
- 6 reasons patients drop out of clinical trials and 6 ways to fix it
- If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
